High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers

Paula Vainio; Laura Lehtinen; Mika Hilvo; T. Mirtti; John Mpindi; Pekka Kohonen; Vidal Fey; Kirsi Ketola; K. Alanen; Merja Perälä; Matej Oresic; Olli Kallioniemi; Kristiina Iljin

High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers

Paula Vainio
, Laura Lehtinen
, Mika Hilvo
, T. Mirtti
, John Mpindi
, Pekka Kohonen
, Vidal Fey
, Kirsi Ketola
, K. Alanen
, Merja Perälä
, Matej Oresic
, Olli Kallioniemi
, Kristiina Iljin

BA6308 Health data analytics

VTT (former employee or external)

Research output: Contribution to conference › Conference article › Scientific

Original language	English
Publication status	Published - 2010
MoE publication type	Not Eligible
Event	Insights in Cancer Progression and Invasion - Helsinki, Finland Duration: 3 Jun 2010 → 4 Jun 2010

Conference

Conference	Insights in Cancer Progression and Invasion
Country/Territory	Finland
City	Helsinki
Period	3/06/10 → 4/06/10

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

Vainio, P., Lehtinen, L., Hilvo, M., Mirtti, T., Mpindi, J., Kohonen, P., Fey, V., Ketola, K., Alanen, K., Perälä, M., Oresic, M., Kallioniemi, O., & Iljin, K. (2010). High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers. Paper presented at Insights in Cancer Progression and Invasion, Helsinki, Finland.

@conference{f80512850d554fe19a712598d75cf802,

title = "High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers",

author = "Paula Vainio and Laura Lehtinen and Mika Hilvo and T. Mirtti and John Mpindi and Pekka Kohonen and Vidal Fey and Kirsi Ketola and K. Alanen and Merja Per{\"a}l{\"a} and Matej Oresic and Olli Kallioniemi and Kristiina Iljin",

year = "2010",

language = "English",

note = "Insights in Cancer Progression and Invasion ; Conference date: 03-06-2010 Through 04-06-2010",

}

Vainio, P, Lehtinen, L, Hilvo, M, Mirtti, T, Mpindi, J, Kohonen, P, Fey, V, Ketola, K, Alanen, K, Perälä, M, Oresic, M, Kallioniemi, O & Iljin, K 2010, 'High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers', Paper presented at Insights in Cancer Progression and Invasion, Helsinki, Finland, 3/06/10 - 4/06/10.

TY - CONF

T1 - High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers

AU - Vainio, Paula

AU - Lehtinen, Laura

AU - Hilvo, Mika

AU - Mirtti, T.

AU - Mpindi, John

AU - Kohonen, Pekka

AU - Fey, Vidal

AU - Ketola, Kirsi

AU - Alanen, K.

AU - Perälä, Merja

AU - Oresic, Matej

AU - Kallioniemi, Olli

AU - Iljin, Kristiina

PY - 2010

Y1 - 2010

M3 - Conference article

T2 - Insights in Cancer Progression and Invasion

Y2 - 3 June 2010 through 4 June 2010

ER -